{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:31:55Z","timestamp":1760297515890},"reference-count":47,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell lymphoma\/leukemia (ATL). The HTLV-1 envelope gene exhibits limited variability when examined from infected individuals, but has not been tested using infectious clones of the virus in animal models. In vitro assays indicate that HTLV-1 envelope (Env) Ser75Ile, Asn95Asp, and Asn195Asp surface unit (SU) mutants are able to replicate in and immortalize lymphocytes. Herein, we examined the effects of these Env mutants in rabbits inoculated with HTLV-1 immortalized ACH.75, ACH.95, or ACH.195 cell lines (expressing full-length molecular clones with the SU mutations) or the ACH.1 cell line (expressing wild-type SU). All rabbits became infected, and the fidelity of the mutations was maintained throughout the 8-week study. However, SU point mutations resulted in decreased antibody responses to viral group-associated antigen (Gag) and Env antigens. ACH.195 rabbits had a selective decreased antibody response to SU, and one ACH.195 rabbit had an antibody response to both HTLV-1 and HTLV-2 SUs. Some mutant inoculation groups had altered proviral loads. However, peripheral-blood mononuclear cell (PBMC) proviral loads did not correlate with antibody responses. Our data are the first to demonstrate that mutations in critical determinants of HTLV-1 Env SU altered antibody responses and proviral loads, but do not prevent viral replication in vivo.<\/jats:p>","DOI":"10.1182\/blood-2005-03-1076","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T02:43:33Z","timestamp":1122432213000},"page":"3602-3608","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations"],"prefix":"10.1182","volume":"106","author":[{"given":"Lee R.","family":"Silverman","sequence":"first","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Phipps","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Montgomery","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Fernandez","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Tsukahara","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Ratner","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Lairmore","sequence":"additional","affiliation":[{"name":"From the Center for Retrovirus Research and Department of Veterinary Biosciences, the Center for Biostatistics, and the Comprehensive Cancer Center, The Arthur James Cancer Hospital and Research Institute, The Ohio State University, Columbus, OH; the Department of Microbiology and Immunology, Shinshu University School of Medicine, Nagano, Japan; and the Department of Medicine, Pathology, and Molecular Microbiology, Washington University School of Medicine, St Louis, MO."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021217351031300_REF1","unstructured":"Mahieux R, Gessain A. HTLV-1 and associated adult T-cell leukemia\/lymphoma. Rev Clin Exp Hematol. 2003;7: 336-361."},{"key":"2020021217351031300_REF2","doi-asserted-by":"crossref","unstructured":"Yamaguchi K, Takatsuki K. Adult T cell leukaemia-lymphoma. Clin Haematol. 1993;6: 899-915.","DOI":"10.1016\/S0950-3536(05)80183-0"},{"key":"2020021217351031300_REF3","doi-asserted-by":"crossref","unstructured":"Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79: 428-437.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"2020021217351031300_REF4","doi-asserted-by":"crossref","unstructured":"Mueller NE, Blattner WA. Retroviruses: human T-cell lymphotropic virus. In: Evans AS and Kaslow RA, eds. Viral Infections of Humans: Epidemiology and Control. 4th ed. New York, NY: Plenum Publishing Corporation; 1997: 785-814.","DOI":"10.1007\/978-1-4899-0036-4_25"},{"key":"2020021217351031300_REF5","doi-asserted-by":"crossref","unstructured":"De BK, Lairmore MD, Griffis K, et al. Comparative analysis of nucleotide sequences of the partial envelope gene (5\u2032 domain) among human T lymphotropic virus type I (HTLV-I) isolates. Virology. 1991;182: 413-419.","DOI":"10.1016\/0042-6822(91)90692-5"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Daenke S, Nightingale S, Cruickshank JK, Bangham CRM. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990;64: 1278-1282.","DOI":"10.1128\/JVI.64.3.1278-1282.1990"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci. 1983;80: 3618-3622.","DOI":"10.1073\/pnas.80.12.3618"},{"key":"2020021217351031300_","unstructured":"Tsujimoto A, Teruuchi T, Imamura J, et al. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med. 1988;5: 29-42."},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Malik KT, Even J, Karpas A. Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus\/human T cell leukaemia virus type I (ATLV\/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV\/HTLV-I subgroup. J Gen Virol. 1988;69(pt 7): 1695-1710.","DOI":"10.1099\/0022-1317-69-7-1695"},{"key":"2020021217351031300_REF10","unstructured":"Pique C, Dokhelar MC. The HTLV-1 envelope: an overview. In: Haseltine WA, Wongstaal F, eds. Genetic Structure and Regulation of HIV. New York, NY: Raven Press, Ltd; 1991: 499-510."},{"key":"2020021217351031300_REF11","doi-asserted-by":"crossref","unstructured":"Hattori S, Kiyokawa T, Imagawa K, et al. Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology. 1984;136: 338-347.","DOI":"10.1016\/0042-6822(84)90170-3"},{"key":"2020021217351031300_REF12","doi-asserted-by":"crossref","unstructured":"Lee TH, Coligan JE, Homma T, et al. Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proc Natl Acad Sci U S A. 1984;81: 3856-3860.","DOI":"10.1073\/pnas.81.12.3856"},{"key":"2020021217351031300_REF13","doi-asserted-by":"crossref","unstructured":"Manel N, Kim FJ, Kinet S, et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115: 449-459.","DOI":"10.1016\/S0092-8674(03)00881-X"},{"key":"2020021217351031300_REF14","doi-asserted-by":"crossref","unstructured":"Delamarre L, Rosenberg AR, Pique C, et al. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1): S85-S91.","DOI":"10.1097\/00042560-199600001-00015"},{"key":"2020021217351031300_REF15","doi-asserted-by":"crossref","unstructured":"Astier-Gin T, Portail JP, Londos-Gagliardi D, et al. Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states. J Infect Dis. 1997;175: 716-719.","DOI":"10.1093\/infdis\/175.3.716"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Palker T, Tanner M, Scearce R, et al. Mapping of immunogenic regions of human T-cell leukemia virus type 1 (HTLV-I) gp46 and gp21 envelope glycoproteins with Env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol. 1989;142: 971-978.","DOI":"10.4049\/jimmunol.142.3.971"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Baba E, Nakamura M, Tanaka Y, et al. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-I) identified by human monoclonal antibodies: a basis for the design of an HTLV-1 peptide vaccine. J Immunol. 1993;151: 1013-1024.","DOI":"10.4049\/jimmunol.151.2.1013"},{"key":"2020021217351031300_REF18","doi-asserted-by":"crossref","unstructured":"Kuroki M, Nakamura M, Itoyama Y, et al. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T-cell leukemia virus type 1. J Immunol. 1992;149: 940-948.","DOI":"10.4049\/jimmunol.149.3.940"},{"key":"2020021217351031300_REF19","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Tanaka R, Terada E, et al. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol. 1994;68: 6323-6331.","DOI":"10.1128\/JVI.68.10.6323-6331.1994"},{"key":"2020021217351031300_REF20","doi-asserted-by":"crossref","unstructured":"Delamarre L, Pique C, Pham D, Tursz T, Dokhelar MC. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol. 1994;68: 3544-3549.","DOI":"10.1128\/JVI.68.6.3544-3549.1994"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Le Blanc I, Grange MP, Delamarre L, et al. HTLV-1 structural proteins. Virus Res. 2001;78: 5-16.","DOI":"10.1016\/S0168-1702(01)00278-7"},{"key":"2020021217351031300_REF22","doi-asserted-by":"crossref","unstructured":"Pique C, Tursz T, Dokhelar MC. Mutations introduced along the HTLV-I envelope gene result in a non functional protein: a basis for envelope conservation? EMBO J. 1990;9: 4243-4248.","DOI":"10.1002\/j.1460-2075.1990.tb07872.x"},{"key":"2020021217351031300_REF23","doi-asserted-by":"crossref","unstructured":"Delamarre L, Rosenberg AR, Pique C, Pham D, Dokhelar MC. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol. 1997;71: 259-266.","DOI":"10.1128\/JVI.71.1.259-266.1997"},{"key":"2020021217351031300_REF24","doi-asserted-by":"crossref","unstructured":"Rosenberg JR, Delamarre L, Pique C, Pham D, Dokhelar MC. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J Virol. 1997;71: 7180-7186.","DOI":"10.1128\/JVI.71.10.7180-7186.1997"},{"key":"2020021217351031300_REF25","doi-asserted-by":"crossref","unstructured":"Kimata JT, Wong F, Wang J, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994;204: 656-664.","DOI":"10.1006\/viro.1994.1581"},{"key":"2020021217351031300_REF26","doi-asserted-by":"crossref","unstructured":"Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000;74: 1094-1100.","DOI":"10.1128\/JVI.74.3.1094-1100.2000"},{"key":"2020021217351031300_REF27","doi-asserted-by":"crossref","unstructured":"Collins ND, Newbound GC, Albrecht B, et al. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 1998;91: 4701-4707.","DOI":"10.1182\/blood.V91.12.4701"},{"key":"2020021217351031300_REF28","doi-asserted-by":"crossref","unstructured":"Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004;78: 3837-3845.","DOI":"10.1128\/JVI.78.8.3837-3845.2004"},{"key":"2020021217351031300_REF29","doi-asserted-by":"crossref","unstructured":"Ye J, Silverman L, Lairmore MD, Green PL. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood. 2003;102: 3963-3969.","DOI":"10.1182\/blood-2003-05-1490"},{"key":"2020021217351031300_REF30","doi-asserted-by":"crossref","unstructured":"Tsukahara T, Wielgosz MM, Ratner L. Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization. J Virol. 2001;75: 9553-9559.","DOI":"10.1128\/JVI.75.19.9553-9559.2001"},{"key":"2020021217351031300_REF31","doi-asserted-by":"crossref","unstructured":"Collins ND, Newbound GC, Ratner L, Lairmore MD. In vitro CD4(+) lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol. 1996;70: 7241-7246.","DOI":"10.1128\/JVI.70.10.7241-7246.1996"},{"key":"2020021217351031300_REF32","doi-asserted-by":"crossref","unstructured":"Miley WJ, Suryanarayana K, Manns A, et al. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses. 2000;16: 665-675.","DOI":"10.1089\/088922200308891"},{"key":"2020021217351031300_REF33","doi-asserted-by":"crossref","unstructured":"Blanchard S, Astier-Gin T, Tallet B, et al. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies. J Virol. 1999;73: 9369-9376.","DOI":"10.1128\/JVI.73.11.9369-9376.1999"},{"key":"2020021217351031300_REF34","doi-asserted-by":"crossref","unstructured":"Tanaka Y, Zeng L, Shiraki H, Shida H, Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol. 1991;147: 354-360.","DOI":"10.4049\/jimmunol.147.1.354"},{"key":"2020021217351031300_REF35","doi-asserted-by":"crossref","unstructured":"Gabet AS, Gessain A, Wattel E. High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys. Int J Cancer. 2003;107: 74-83.","DOI":"10.1002\/ijc.11329"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Hashimoto K, Higuchi I, Osame M, Izumo S. Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM\/TSP and asymptomatic carriers. J Neurol Sci. 1998;159: 67-72.","DOI":"10.1016\/S0022-510X(98)00138-5"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. J Neurovirol. 1998;4: 586-593.","DOI":"10.3109\/13550289809114225"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Shinzato O, Ikeda S, Momita S, et al. Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood. 1991;78: 2082-2088.","DOI":"10.1182\/blood.V78.8.2082.2082"},{"key":"2020021217351031300_REF39","doi-asserted-by":"crossref","unstructured":"Kamihira S, Dateki N, Sugahara K, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003;25: 111-117.","DOI":"10.1046\/j.1365-2257.2003.00503.x"},{"key":"2020021217351031300_REF40","doi-asserted-by":"crossref","unstructured":"Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg. 1997;57: 142-148.","DOI":"10.4269\/ajtmh.1997.57.142"},{"key":"2020021217351031300_","unstructured":"Pancake BA, Zucker-Franklin D, Marmor M, Legler PM. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I\/II) may require a combination of biomolecular and serological analyses. Proc Assoc Am Physicians. 1996;108: 444-448."},{"key":"2020021217351031300_REF42","doi-asserted-by":"crossref","unstructured":"Liu H, Shah M, Stramer SL, et al. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II. Transfusion. 1999;39: 1185-1193.","DOI":"10.1046\/j.1537-2995.1999.39111185.x"},{"key":"2020021217351031300_","doi-asserted-by":"crossref","unstructured":"Hartley TM, Khabbaz RF, Cannon RO, Kaplan JE, Lairmore MD. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990;28: 646-650.","DOI":"10.1128\/JCM.28.4.646-650.1990"},{"key":"2020021217351031300_REF44","doi-asserted-by":"crossref","unstructured":"Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992;326: 375-380.","DOI":"10.1056\/NEJM199202063260604"},{"key":"2020021217351031300_REF45","doi-asserted-by":"crossref","unstructured":"Yang YC, Hsu TY, Liu MY, et al. Molecular subtyping of human T-lymphotropic virus type I (HTLV-I) by a nested polymerase chain reaction-restriction fragment length polymorphism analysis of the envelope gene: two distinct lineages of HTLV-I in Taiwan. J Med Virol. 1997;51: 25-31.","DOI":"10.1002\/(SICI)1096-9071(199701)51:1<25::AID-JMV4>3.0.CO;2-U"},{"key":"2020021217351031300_REF46","doi-asserted-by":"crossref","unstructured":"Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia. 2003;17: 26-38.","DOI":"10.1038\/sj.leu.2402777"},{"key":"2020021217351031300_REF47","doi-asserted-by":"crossref","unstructured":"Mortreux F, Leclercq I, Gabet AS, et al. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst. 2001;93: 367-377.","DOI":"10.1093\/jnci\/93.5.367"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3602\/1636899\/zh802205003602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/10\/3602\/1636899\/zh802205003602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T04:29:00Z","timestamp":1706416140000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/10\/3602\/20962\/In-vivo-analysis-of-replication-and-immunogenicity"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,15]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-03-1076","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,15]]}}}